Dr. Victoria G. Farley, a board-certified dermatologist with Vivida Dermatology in Las Vegas, joins me for an in-depth conversation about hidradenitis suppurativa (HS), clinical trials, and the importance of patient access. Dr. Farley’s unique background, completing dual residencies in dermatology and internal medicine, gives her a deep understanding of complex skin conditions and their impact on overall health.

DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.

We first connected at the ‘I Reclaim' Summit where Dr. Victoria Farley spoke on surgical options for HS. She shares how surgical decisions are made, the role of medical management alongside surgery, and why not every dermatologist or surgeon is equally equipped to treat HS. We talk about the importance of pre-surgical medical therapy and how biologics can make a meaningful difference for patients.

Our conversation dives into Dr. Farley’s passion for medical dermatology and the personal experiences that shaped her career. She also offers a behind-the-scenes look at clinical trials; how they work, why they’re so valuable, and how they can give patients access to cutting-edge treatments at no cost. We explore common concerns patients have about joining trials, how side effects are recorded (yes, even minor ones!), and what’s currently in the HS treatment pipeline.

Dr. Victoria G. Farley also opens up about the challenges of getting medications approved, the roadblocks physicians face with insurance companies, and her hopes for the next generation of dermatologists. If you’re interested in how new treatments come to market, what’s ahead for HS care, or why access to the right specialist matters, you’ll love this conversation.

This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners and creatives.